Recent Posts

Is Fuel Tech (NASDAQ:FTEK) a Sell? What does H.C. Wainwright Think?

Is Fuel Tech (NASDAQ:FTEK) a Sell? What does H.C. Wainwright Think?

Investors sentiment decreased to 1.13 in Q2 2018. Its down 0.25, from 1.38 in 2018Q1. It dived, as 4 investors sold Fuel Tech, Inc. shares while 4 reduced holdings. 2 funds opened positions while 7 raised stakes. 5.48 million shares or 4.64% more from 5.23 million shares in 2018Q1 were […]

Citigroup Has Just Reaffirmed $118 Target Price Per Share on DTE Energy (NYSE:DTE) stock, While They’ve Also Reiterated Their Neutral Rating

Citigroup Has Just Reaffirmed $118 Target Price Per Share on DTE Energy (NYSE:DTE) stock, While They’ve Also Reiterated Their Neutral Rating

Investors sentiment increased to 0.97 in Q2 2018. Its up 0.08, from 0.89 in 2018Q1. It increased, as 45 investors sold DTE Energy Company shares while 156 reduced holdings. 46 funds opened positions while 148 raised stakes. 125.98 million shares or 1.78% more from 123.78 million shares in 2018Q1 were […]

Dollar General (NYSE:DG): Citigroup Reiterates Buy Rating Today, Has a Target of $120/Share

Dollar General (NYSE:DG): Citigroup Reiterates Buy Rating Today, Has a Target of $120/Share

Investors sentiment increased to 1.26 in Q2 2018. Its up 0.19, from 1.07 in 2018Q1. It improved, as 48 investors sold Dollar General Corporation shares while 185 reduced holdings. 88 funds opened positions while 205 raised stakes. 238.45 million shares or 2.45% more from 232.75 million shares in 2018Q1 were […]

Breaking: Citigroup Keeps $28 Target Price On Audentes Therapeutics (BOLD) Shares, Keeps Their Original “Neutral” Rating

Breaking: Citigroup Keeps $28 Target Price On Audentes Therapeutics (BOLD) Shares, Keeps Their Original “Neutral” Rating

Audentes Therapeutics (BOLD) Rating Reaffirmed EU: In an analyst note revealed to clients and investors on Monday, 10 December, Citigroup reconfirmed their “Neutral” rating on Audentes Therapeutics (BOLD) shares. They now have a $28 PT on the company. Citigroup’s target indicates a potential upside of 20.07 % from the company’s […]

Blink Charging (BLNK) Sees Coverage Initiated By H.C. Wainwright with a $5 Price

Why Has H.C. Wainwright Given Blink Charging (BLNK) a $5 Price Target H.C. Wainwright analyst started coverage with a “Buy” rating on Blink Charging (BLNK) today and set a price target of $5. The company’s shares opened today at 2.07. The stock decreased 1.90% or $0.04 during the last trading […]

Citigroup Reaffirmed Big Lots (NYSE:BIG) As a “Buy”; They Now Have a Price Objective Of $36

Citigroup Reaffirmed Big Lots (NYSE:BIG) As a “Buy”; They Now Have a Price Objective Of $36

Investors sentiment decreased to 0.77 in Q2 2018. Its down 0.20, from 0.97 in 2018Q1. It turned negative, as 69 investors sold Big Lots, Inc. shares while 82 reduced holdings. 37 funds opened positions while 80 raised stakes. 45.33 million shares or 9.08% less from 49.86 million shares in 2018Q1 […]

Citigroup Maintains Bunge (NYSE:BG) As a Buy; They Now Have a Target Of $80

Citigroup Maintains Bunge (NYSE:BG) As a Buy; They Now Have a Target Of $80

Investors sentiment decreased to 0.9 in Q2 2018. Its down 0.25, from 1.15 in 2018Q1. It fall, as 51 investors sold Bunge Limited shares while 114 reduced holdings. 47 funds opened positions while 102 raised stakes. 108.80 million shares or 0.40% more from 108.36 million shares in 2018Q1 were reported. […]

Key Research Analysts at Citigroup Kept the Same their ‘Buy’ rating for Adobe (NASDAQ:ADBE) Shares Today. Their Price Objective is Set to $300

Key Research Analysts at Citigroup Kept the Same their ‘Buy’ rating for Adobe (NASDAQ:ADBE) Shares Today. Their Price Objective is Set to $300

Investors sentiment increased to 0.97 in Q2 2018. Its up 0.07, from 0.9 in 2018Q1. It improved, as 40 investors sold Adobe Inc. shares while 411 reduced holdings. 119 funds opened positions while 320 raised stakes. 398.19 million shares or 1.84% less from 405.65 million shares in 2018Q1 were reported. […]

Is ACADIA Pharmaceuticals (NASDAQ:ACAD) Finally Worth Your Time? What Does Canaccord Genuity Think?

Is ACADIA Pharmaceuticals (NASDAQ:ACAD) Finally Worth Your Time? What Does Canaccord Genuity Think?

Investors sentiment increased to 1.22 in 2018 Q2. Its up 0.33, from 0.89 in 2018Q1. It is positive, as 31 investors sold ACADIA Pharmaceuticals Inc. shares while 43 reduced holdings. 35 funds opened positions while 55 raised stakes. 114.30 million shares or 4.25% less from 119.37 million shares in 2018Q1 […]

Apple (NASDAQ:AAPL) “Buy” Rating Reconfirmed Today By Citigroup; The Target Price per Share is $200

Apple (NASDAQ:AAPL) “Buy” Rating Reconfirmed Today By Citigroup; The Target Price per Share is $200

Investors sentiment increased to 0.71 in 2018 Q2. Its up 0.02, from 0.69 in 2018Q1. It increased, as 57 investors sold Apple Inc. shares while 1002 reduced holdings. 132 funds opened positions while 622 raised stakes. 2.77 billion shares or 3.26% less from 2.86 billion shares in 2018Q1 were reported. […]